FDA
-
-
-
-
-
-
-
Grace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA Review
-
-
-
-
-
-
-
Grace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business Update
-
-
-
-
-
-
-
Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
-
-
-
-
-
-
-
Grace Therapeutics to Participate in Upcoming Investor Events January 2025
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

